Early biomarker for AKi
Mori, K.; Mukoyama, M.; Nakao, K.
Nihon Jinzo Gakkai Shi 52(5): 566-571
2010
ISSN/ISBN: 0385-2385 PMID: 20715588 Document Number: 640296
Document emailed within 1 workday
Related Documents
Takagi, A.; Sai, K.; Umemura, T.; Hasegawa, R.; Kurokawa, Y. 1992: Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 11(3): 145-149Verderio, P.; Mangia, A.; Orlando, C.; Belfiglio, M.; Marchetti, A.; Bertario, L.; Chiappetta, G.; Gion, M.; Tonini, G.Paolo.; Podo, F.; Vocaturo, A.; Silvestrini, R.; Lombardo, C.; Paradiso, A. 2010: Research trends for early cancer biomarker detection in Italy: an integrated program in oncology (PIO) survey Tumori 96(5): 721-725
Zhang, X.; Guan, L.; Huang, K. 2012: Significance and importance of using micronucleus frequencies in peripheral blood lymphocytes as a biomarker for assessing early health of workers exposed to polycyclic aromatic hydrocarbon Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 30(12): 968-971
Ogawa, S. 2014: Biomarker Nihon Rinsho. Japanese Journal of Clinical Medicine 72(9): 1578-1584
Nagasaka, T.; Mori, Y.; Umeda, Y.; Fujiwara, T. 2012: Biomarker for colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(5): 802-808
Miyazaki, J.; Nishiyama, H. 2012: Biomarker for bladder cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(1): 48-53
Presl, J.; Kučera, R.; Topolčan, O.; Novotný, Z.; Vrzalová, J.; Fuchsova, R.; Betincová, L.; Rokyta, Z. 2012: HE4 a biomarker of ovarian cancer Ceska Gynekologie 77(5): 445-449
Gunn, L.; Smith, M.T. 2004: Emerging biomarker technologies Iarc Scientific Publications 2004(157): 437-450
Yucel, E.; Ilter, E.; Aksungar, F.B.; Celik, A.; Peker, B.H.; Serifsoy, E.; Bozkurt, S. 2017: HE4: really a novel biomarker for ovarian cancer? European Journal of Gynaecological Oncology 38(1): 59-64
Kondo, T. 2012: Biomarker development by cancer proteomics Nihon Rinsho. Japanese Journal of Clinical Medicine 70(5): 754-758
Myers, R.B.; Grizzle, W.E. 1996: Biomarker expression in prostatic intraepithelial neoplasia European Urology 30(2): 153-166
Nagai, S. 2015: Exploratory biomarker analyses and companion diagnostics Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 126-130
Lynch, H.T.; Schuelke, G.S.; Lynch, J.F. 1985: Biomarker studies in hereditary ovarian carcinoma Cancer Detection and Prevention 8(1-2): 129-134
Uemura, Y.; Hayashi, H.; Takahashi, T.; Saitho, T.; Umeda, R.; Ichise, Y.; Sendo, S.; Tsuji, G.; Kumagai, S. 2015: MMP-3 as a Biomarker of Disease Activity of Rheumatoid Arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 63(12): 1357-1364
Soejima, H.; Kishikawa, H.; Ogawa, H. 2011: Inflammatory biomarker for diagnosis of coronary diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 74-78
Smalley, D.M.; Ley, K. 2008: Plasma-Derived Microparticles for Biomarker Discovery Clinical Laboratory 54(3-4): 67-79
Bhalla, V.; Maisel, A.S. 2004: B-type natriuretic peptide. a biomarker for all the right reasons Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 417-420
Kondo, T. 2012: Proteomics for biomarker development toward personalized medicine Rinsho Byori. Japanese Journal of Clinical Pathology 60(7): 644-649
Lucignani, G.; Bastianello, S. 2007: Pharmacological MRI: a biomarker in CNS drug discovery and development? Functional Neurology 22(2): 71-73
Matsusaka, S. 2009: Biomarker for chemotherapy in patients with colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(1): 11-14